Trial Summary
What is the purpose of this trial?
This study is a double-blind, randomized, placebo-controlled trial to evaluate the use of high frequency TENS for pain control during IUD insertion. Transcutaneous electrical nerve stimulation (TENS) is a relatively low-cost, low-risk, non-pharmacologic intervention for pain management. Previous studies have found that TENS reduces pain associated with other outpatient gynecological procedures. Participants will be randomized in a 1:1 ratio to either active treatment or placebo (placebo TENS) and record pain scores using a 100 mm visual analog scale (VAS) at the time of IUD insertion. The same device will be used for both active and placebo treatment.
Do I need to stop taking my current medications to join the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, you cannot participate if you have used opioids in the last 30 days or have a contraindication to ibuprofen.
What data supports the idea that TENS for IUD Insertion Pain is an effective treatment?
The available research shows that TENS is effective in providing pain relief during delivery, which is a similar type of pain management. In one study, 44% of women reported good to very good pain relief, and another 44% experienced moderate relief. In a second study, 47% of women found TENS to be good or very good for pain relief, with 42% experiencing some effect. These results suggest that TENS can be a useful treatment for managing pain, similar to what might be experienced during IUD insertion.12345
What safety data exists for TENS treatment?
TENS has been studied for pain relief in various contexts, including labor and delivery, with no reported side effects for mothers or fetuses. A systematic review and meta-analysis of 381 studies also investigated the safety of TENS for acute and chronic pain in adults, suggesting it is a safe method for pain management.13467
Is TENS a promising treatment for pain during IUD insertion?
Research Team
Lauren Kus, MD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Eligibility Criteria
This trial is for individuals experiencing pain during IUD insertion. Participants should be those undergoing the procedure and willing to use a TENS device for pain management. Specific eligibility details are not provided, but typically include being of reproductive age and in good general health.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either active TENS or placebo TENS during IUD insertion
Follow-up
Participants complete surveys to rate pain and reflect on their experience with IUD insertion and TENS device
Treatment Details
Interventions
- Transcutaneous Electrical Nerve Stimulation (TENS) (Behavioural Intervention)
Transcutaneous Electrical Nerve Stimulation (TENS) is already approved in Canada for the following indications:
- Chronic pain
- Acute pain
- Postoperative pain
- Low back pain
- Osteoarthritis pain
- Diabetic peripheral neuropathy
- Fibromyalgia
- Neuropathic pain
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
Dr. Brendan Carr
Icahn School of Medicine at Mount Sinai
Chief Executive Officer since 2024
MD, MA, MS
Dr. Vicki LoPachin
Icahn School of Medicine at Mount Sinai
Chief Medical Officer
MD, FACP, MBA